Lupin, Merck KGaA In Advanced Talks For Complex Generics Deal

Changing landscape of the global pharmaceutical market is likely bringing India’s Lupin and German’s Merck closer. Industry sources say a deal is close to being announced.

More from India

More from Focus On Asia